See All Slides - tctmd.com

Slides

Presentation TCT 2017

PFO Closure for Migraine: Dead, Alive, or in Need of Another Trial?

Presenter: Mark Reisman, Brian K. Whisenant, Robert J. Sommer

November 01, 2017

Presentation TCT 2017

Flash Debate 3: Should the Rapidly Improving and Asymptomatic Patient With Significant Vessel Occlusion Be Treated (and When)? Yes!

Presenter: Nick Hopkins, Aman B. Patel, Adnan Siddiqui

November 01, 2017

Presentation TCT 2017

Case #12 (With Discussion): An Unusual Case of Scaffold Failure Within 1 Year

Presenter: Hiram G. Bezerra, Nick E. J. West, Niels R. Holm

November 01, 2017

Presentation TCT 2017

CULPRIT-SHOCK: Appreciation and Critique

Presenter: Martin B. Leon, Marco Valgimigli, Cindy L. Grines

November 01, 2017

Presentation TCT 2017

The Clinical Relevance of Valve Leaflet Thickening after TAVR

Presenter: Raj Makkar

November 01, 2017

Presentation TCT 2017

Update on the Harmony Transcatheter PV and Other TPV Products Inside and OUS for Severe PR

Presenter: Elchanan Bruckheimer, Doff B. McElhinney, Lee N. Benson

November 01, 2017

Presentation TCT 2017

Closing Thoughts: What Are the Unmet Needs in Acute and Chronic Heart Failure, and How Will We Close the Gap?

Presenter: Ulrich P. Jorde, Michael Mooney, Hiroo Takayama, Javed Butler

November 01, 2017

Presentation TCT 2017

VTE and PFO Closure: Device? Anticoagulation? Both?

Presenter: Mark Reisman, Brian K. Whisenant, Christian Spies

November 01, 2017

Presentation TCT 2017

CULPRIT-SHOCK: Highlights Summary

Presenter: Martin B. Leon, Marco Valgimigli, Georg Fuernau, MD

November 01, 2017

Presentation TCT 2017

CULPRIT-SHOCK: Highlights Summary

Presenter: Martin B. Leon, Marco Valgimigli, Georg Fuernau, MD

November 01, 2017

Advertisement

Slides

PFO Closure for Migraine: Dead, Alive, or in Need of Another Trial?

Flash Debate 3: Should the Rapidly Improving and Asymptomatic Patient With Significant Vessel Occlusion Be Treated (and When)? Yes!

Case #12 (With Discussion): An Unusual Case of Scaffold Failure Within 1 Year

CULPRIT-SHOCK: Appreciation and Critique

The Clinical Relevance of Valve Leaflet Thickening after TAVR

Update on the Harmony Transcatheter PV and Other TPV Products Inside and OUS for Severe PR

Closing Thoughts: What Are the Unmet Needs in Acute and Chronic Heart Failure, and How Will We Close the Gap?

VTE and PFO Closure: Device? Anticoagulation? Both?

CULPRIT-SHOCK: Highlights Summary

CULPRIT-SHOCK: Highlights Summary

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content